future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 20/05/2026 00:05:07 AM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 20/05/2026 00:05:47 AM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 23:05:29 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 23:05:06 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 23:05:22 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 22:05:02 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 22:05:37 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 22:05:45 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 22:05:56 PM | Salario: S/. No Especificado | Empresa:
BridgeBio future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use... that is critically important to BridgeBio's success. The launch of Encaleret will introduce a first-in-class drug for ADH1, or autosomal...
Lugar:
USA | 19/05/2026 21:05:33 PM | Salario: S/. No Especificado | Empresa:
BridgeBio